Skip to content

Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients

Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02529371
Enrollment
30
Registered
2015-08-20
Start date
2015-09-30
Completion date
2015-10-31
Last updated
2015-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence

Brief summary

The study will evaluate device performance and user satisfaction in the UriCap-RM, an FDA cleared non-invasive urine collection device for men.

Detailed description

Following various disease conditions such as trauma, orthopedic surgery, and infections etc., patients may be bedridden and unable to void in a bedpan or to make their way to the toilet. Others may be incontinent of urine. In such situations an indwelling catheter is often placed to relieve patients while they are incapacitated; in many cases a catheter is placed despite lack of urinary retention. Indwelling catheters, although effective, are associated with discomfort, pain, and urinary tract infections. In other cases diapers or absorbent pads may be used, or a condom-type urine collection device. These may be associated with skin irritation and infection. The study will evaluate the UriCap-RM non-invasive urine collection device in hospitalized men.

Interventions

DEVICEUriCap-RM

UriCap-RM is comprised of a reusable part and a single use adhesive tape. The reusable part is applied over the urethral meatus and is held in position by a stabilizer and adhesive tape. It is connected to a standard urine collection bag. The UriCap-RM is used on male patients who would otherwise use diapers, a condom-type urine collection device or an indwelling catheter for urine collection.

Sponsors

G.R. Dome Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male ≥ 18 years old. * Empties the bladder completely on voiding * A clinical indication for an indwelling catheter, use of pads or diapers * Subject has signed an informed consent form, is cooperative and willing to complete all study procedures * Absence of localized disease at the site of device application - no discharge, itching, inflammation or skin condition - - on visual examination * Subject has no hypersensitivity to silicon.

Exclusion criteria

* Known allergy to silicon * Dysuria * Urinary retention - Post-void residual urine more than 300cc * Hematuria or pyuria (turbidity) on visual inspection, according to investigator judgement. * Diagnosed with acute renal failure, according to investigator judgement. * Serious or unstable psychological condition (e.g., eating disorders, clinical depression, anxiety, emotionally labile) which, in the opinion of the Investigator, would compromise the subject's well-being or successful participation in the study * Participating in another clinical study. * Financial interest in the Sponsor Company or a competitor company by subject or a family member

Design outcomes

Primary

MeasureTime frameDescription
Performance of the device in collecting urine1-30 daysMultiple variables will be assessed and their measurements aggregated to arrive at number of events reported: * Patient's anatomy does not enable application of the device * Leakage * Pooling of urine in the tubing * Tubing disconnections * Adhesive tape disconnections * Need for repositioning of device * Device malfunctions
Patient Comfort1-30 daysDaily assessment of comfort rated in the Universal Pain Assessment Scale of 1-10.
Healthcare provider (HCP) satisfaction in device useup to 60 daysNurses will fill a Treatment Satisfaction Questionnaire once after termination of all study patients
Patient Satisfaction in Device Use1-30 daysAdministration of a Treatment Satisfaction Questionnaire at termination of device use.

Secondary

MeasureTime frameDescription
Number of leakage events resulting from device movement1-30 days
Number of patients with Adverse Events that are related to device use1-30 days
Effectiveness of defined device cleaning procedure1-30 daysThe reusable part will be visually inspected after cleaning for suitability for reuse. Devices which exhibit any of the following properties will be discarded: color change, residual soiling, loss of mechanical integrity, torn, rough edges. The effectiveness of the cleaning procedure will be measured as the average number of days the device can be reused.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026